Stanford University
Showing 1,151-1,200 of 7,899 Results
-
Zheng Chen, OD
Clinical Assistant Professor, Ophthalmology
BioDr. Chen is an optometrist with the Byers Eye Institute and a clinical assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Chen diagnoses and treats a range of eye conditions, including refractive errors, glaucoma, cataracts, and diabetic retinopathy. Her clinical experience is in routine and emergency eye care, pre- and post-surgical eye care, and medical management of eye diseases. She delivers patient-focused care, quickly establishing rapport and working effectively with pediatric, geriatric, and culturally diverse populations.
Dr. Chen is a member of Beta Sigma Kappa, an international optometric honor society. -
Grace A Cheney
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioGrace Cheney, M.D. specializes in the assessment and treatment of ADHD across the lifespan. She serves as Director of the Adult ADHD Assessment Clinic at Stanford, which provides structured, developmentally informed evaluations for adults with attention and executive function challenges. Rooted in a neurodiversity-affirming framework, the clinic focuses on diagnostic clarity to support tailored, evidence-based care. As part of this model, the clinic incorporates the California ADHD Symptom Tracking (CAST) initiative, a semi-structured symptom-tracking method that fosters patient insight, supports individualized treatment planning, and promotes adherence.
With subspecialty training in both child and adolescent psychiatry and forensic psychiatry, Dr. Cheney’s diagnostic lens emphasizes precision and developmental context. She has particular expertise in the assessment of ADHD in women, transitional-age youth, and high-functioning professionals. Her treatment approach is comprehensive, and emphasizes establishing foundational non-pharmacological strategies in addition to pharmacological interventions.
Dr. Cheney lectures in the Forensic Psychiatry Fellowship on civil and child forensic topics, and she also supervises psychiatry residents and fellows in adult ADHD assessment. Her emerging areas of interest include the ethical use of AI to maintain therapeutic momentum and accelerate growth between visits, while enriching clinical decision-making with dynamic data that supports more personalized, precise, and adaptive therapy. -
Alan G. Cheng, MD
Edward C. and Amy H. Sewall Professor in the School of Medicine, Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsActive Wnt signaling maintains somatic stem cells in many organ systems. Using Wnt target genes as markers, we have characterized distinct cell populations with stem cell behavior in the inner ear, an organ thought to be terminally differentiated. Ongoing work focuses on delineating the developing significance of these putative stem/progenitor cells and their behavior after damage.
-
Evaline Cheng, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardio-oncology
Cardiotoxicity
Delivery of care
Health care systems -
Paul Cheng MD PhD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford, including a post-doctoral training in the Quertermous lab. His current clinical focus is in amyloidosis and cardio-oncology.
Dr. Cheng pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome. The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.
Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu -
Tiffany Cheng
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioI am a physician leader and anesthesiologist at Stanford Health Care, where I serve as Medical Director of Perioperative Services at SHC Palo Alto and hold a faculty appointment as Clinical Assistant Professor at Stanford University School of Medicine.
My work sits at the intersection of direct patient care and systems-level leadership. I have a track record of building high-performing clinical teams, designing governance structures from the ground up, and delivering measurable operational impact — including significant improvements in OR utilization, block efficiency, and access to care across Stanford's interventional platform.
I founded Stanford's Anesthesiology Mentorship Program (AMP), a faculty development initiative that received the Augustus A. White III Award, and co-founded ASPIRE, a multi-institutional speaker exchange network. I am a graduate of Stanford's Physician Leadership Certificate Program and will begin an Executive MBA at Santa Clara University in Fall 2026.
I believe that the strongest clinical institutions are built on trust, accountability, and a genuine investment in the people doing the work — and I bring that conviction to every leadership role I hold. -
Xingxing Shelley Cheng
Assistant Professor of Medicine (Nephrology) and, by courtesy, of Surgery (Abdominal Transplantation) and of Health Policy
Current Research and Scholarly InterestsDr. Xingxing Cheng's expertise is in applying the tools of decision science to clinical practice and policy analysis. Her current research is in the following areas:
1) the costs, effectiveness, and implementation of work-up before kidney transplantation, including pretransplant cardiovascular screening;
2) ethics of and decision-making in in multi-organ transplantation. -
David Cheriton
Professor of Computer Science, Emeritus
BioCheriton's research includes the areas of high-performance distributed systems, and high-speed computer communication with a particular interest in protocol design. He leads the Distributed Systems Group in the TRIAD project, focused on understanding and solving problems with the Internet architecture. He has also been teaching and writing about object-oriented programming, building on his experience with OOP in systems building.
-
Athena Cherry
Member, Stanford Cancer Institute
Current Research and Scholarly InterestsThe use of molecular and molecular cytogenetic methods to identify chromosomal abnormalities in acquired and congenital disorders.
-
Mike Cherry
Professor (Research) of Genetics, Emeritus
Current Research and Scholarly InterestsMy research involves identifying, validating and integrating scientific facts into encyclopedic databases essential for research and scientific education. Published results of scientific experimentation are a foundation of our understanding of the natural world and provide motivation for new experiments. The combination of in-depth understanding reported in the literature with computational analyses is an essential ingredient of modern biological research.
-
Glenn M. Chertow
Norman S. Coplon/Satellite Healthcare Professor of Medicine and Professor, by courtesy, of Epidemiology and Population Health and of Health Policy
On Partial Leave from 2026-08-01 To 2026-08-30Current Research and Scholarly Interestsclinical epidemiology, health services research, decision sciences, clinical trials in acute and chronic kidney disease
-
Christopher Cheung, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Christopher Cheung is a board-certified, fellowship-trained pain medicine specialist and anesthesiologist at the Stanford Health Care Pain Management Center. He is also a clinical assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine.
Dr. Cheung cares for patients with a wide range of acute and chronic pain conditions, including spine-related pain, neuropathic pain, and postsurgical pain. He specializes in using medications and interventional procedures such as nerve blocks, spine injections, radiofrequency ablation, and neuromodulation to improve function and quality of life. Working closely with patients from diagnosis through treatment, Dr. Cheung focuses on providing personalized, high-quality care.
Dr. Cheung’s research has explored innovative neuromodulation techniques and evidence-based strategies for pain management after surgery. His work has been presented at national conferences and published in peer-reviewed journals. -
Emilie Cheung, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsPyrocarbon humeral head replacement
Clinical outcome after shoulder replacement
Clinical outcome after elbow replacement
Clinical outcomes following complex reconstruction of the shoulder and elbow,
Bone mineral density in the shoulder,
3D kinematics of the shoulder girdle after arthroplasty -
Ramsey Cheung
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Cheung's research interests focus on liver diseases, with emphasis on viral hepatitis. His past research include investigating the mechanism of viral neutralization of hepatitis B virus at the molecular level and immune response to hepatitis C virus. Dr. Cheung is studing various aspects of hepatitis C, both clinical and translational research.
-
Kevin Wei-Han Chi
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsMedical Student Education, Patient Education, High Value Care
-
Angela Chiang
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Angela Chiang is a board-certified family medicine physician.
-
Audris Chiang, MD
Clinical Scholar, Dermatology
Postdoctoral Scholar, DermatologyBioAudris Chiang, MD is a Clinical Scholar and Postdoctoral Research Scholar of Dermatology. She received undergraduate degrees in Computer Science and Economics at UC Berkeley, and obtained her medical degree at UC Irvine. She completed dermatology residency training at Stanford in the 2+1 basic science research track. She continues to conduct research in the laboratories of Kavita Sarin, MD PhD and Christina Curtis, PhD, studying the genetics of skin cancers and patients who develop multiple skin cancers. Her clinical interests include general medical dermatology, skin cancer, and atopic dermatitis.
-
E.J. Chichilnisky
John R. Adler Professor, Professor of Neurosurgery and of Ophthalmology and, by courtesy, of Electrical Engineering
On Leave from 2026-08-01 To 2026-12-01Current Research and Scholarly InterestsFunctional circuitry of the retina and design of retinal prostheses
-
Christina F. Chick
Instructor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsMy research examines the mechanistic contributions of sleep, cognition and affect to the onset and course of psychiatric disorders across the lifespan. I am particularly interested in adolescence as a period during which changes in circadian rhythm, sleep architecture, and sleep behavior co-occur with neuroendocrine development, psychosocial changes, and the onset of many psychiatric disorders. Given that sleep is a highly treatable target, increasing our understanding of the specific contributions of sleep to psychiatric symptom onset may facilitate the development of targeted interventions to mitigate the course of illness.
-
Christopher Chidsey
Associate Professor of Chemistry, Emeritus
Current Research and Scholarly InterestsThe Chidsey group research interest is to build the chemical base for molecular electronics. To accomplish this, we synthesize the molecular and nanoscopic systems, build the analytical tools and develop the theoretical understanding with which to study electron transfer between electrodes and among redox species through insulating molecular bridges
-
Yueh-hsiu Chien
Professor of Microbiology & Immunology
Current Research and Scholarly InterestsContribution of T cells to immunocompetence and autoimmunity; how the immune system clears infection, avoids autoimmunity and how infection impacts on the development of immune responses.
-
Nymisha Chilukuri, MD
Clinical Assistant Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsMy research interests are to use clinical informatics to improve access to equitable care for children in under-served communities. My main areas of research interest currently include optimizing clinical informatics solutions for those with non-English preferred languages and improving interoperability between health systems, public health and community partners for pediatric patients and families.
-
Alexander Chin, MD, MBA
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioAlexander Chin, MD, MBA, is a radiation oncologist with Stanford Medicine Cancer Center and a clinical associate professor in the Department of Radiation Oncology with the Stanford School of Medicine. He also serves as Executive Director of Market Development, Cancer Services for Stanford Health Care, acting as a liaison between faculty leadership and hospital administration, to advance Stanford Medicine’s mission of providing compassionate leading-edge care to the communities that we serve.
Dr. Chin is committed to ensuring the delivery of care of the highest quality and value. He provides clinical expertise in diagnosing and treating the full range of cancers, including those of the lung, breast, and central nervous system. In addition, he serves on national leadership teams formed to advance the practice of cancer care. Dr. Chin is currently a member of the Payment Reform Task Force for the American Society of Clinical Oncology and has previously served on their Clinical Practice Committee and as a health policy fellow. He was one of just two oncologists in the US selected to participate in a year-long program on policy leadership.
He currently serves on the Stanford Cancer Network Quality Committee. This team develops and implements our care delivery standards, strategies, and metrics to ensure consistently excellent cancer care from all Stanford Health Care providers in all locations.
Dr. Chin has conducted extensive research and published his findings in numerous peer-reviewed journals. Topics range from novel oncology payment models to the use of new imaging parameters in lung cancer. His scholarship appears in Cancer, JCO Oncology Practice, Clinical Lung Cancer, International Journal of Radiation Oncology, Biology, Physics, and elsewhere.
He has made presentations on stereotactic body radiotherapy (SBRT) and other treatment advances at meetings of the Radiological Society of North America and American Society for Radiation Oncology. He also has addressed these topics as an invited lecturer in training sessions for oncology residents.
He has won numerous awards, including recognition for his research from the Radiological Society of North America. He also has earned honors from the American Society of Clinical Oncology and from his alma maters: the Perelman School of Medicine at the University of Pennsylvania as well as Wharton and Yale.
Dr. Chin earned a Bachelor of Science degree in molecular biophysics and biochemistry from Yale University. He earned his medical degree from Perelman School of Medicine at the University of Pennsylvania, and his MBA at the Wharton School. He completed his residency in Radiation Oncology at Stanford Health Care.
He is a member of the Radiological Society of North America, American Society for Radiation Oncology, and American Society for Clinical Oncology. -
Andrew Chin, DO, MS, MPH
Clinical Assistant Professor, Medicine
BioDr. Andrew Chin is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine and works as a hospitalist at Stanford Health Care. He attended medical school at Midwestern University in Glendale, Arizona and completed his internal medicine residency at University Hospitals of Cleveland in Cleveland, Ohio.
-
Albert Sean Chiou, MD, MBA
Clinical Professor, Dermatology
Current Research and Scholarly InterestsI am a clinical researcher interested in evaluating promising new diagnostic paradigms and treatments for serious or poorly treated, chronic skin conditions. My research currently includes:
Therapeutics:
- Treatments for atopic dermatitis and other inflammatory skin conditions
- Treatments for itch from epidermolysis bullosa
- Treatments for chronic wounds for patients with recessive dystrophic epidermolysis bullosa (In collaboration with Dr. Jean Tang and Dr. Peter Marinkovich)
Diagnostics:
- Artificial intelligence approaches for melanoma and skin cancer early detection
- Imaging mass spectrometry for skin cancer margin analysis and diagnosis
I collaborate with other faculty within the Stanford Skin Innovation and Interventional Research Group (SIIRG) to conduct investigator initiated and sponsored clinical trials seeking to improve care for important dermatologic diseases
Please learn more about our work at: https://siirg.stanford.edu/ -
Gheorghe Chistol
Assistant Professor of Chemical and Systems Biology
Current Research and Scholarly InterestsResearch in my laboratory is aimed at understanding how eukaryotes replicate their DNA despite numerous challenges (collectively known as replication stress), and more generally – how eukaryotic cells safeguard genome integrity. Specifically, we are investigating: (i) mechanisms that regulate the activity of the replicative helicase during replication stress, (ii) mechanisms that control the inheritance of epigenetic information during replication, and (iii) mechanisms of ubiquitin-mediated regulation of genome maintenance. We utilize single-molecule microscopy to directly image fluorescently-labeled replication factors and track them in real time in Xenopus egg extracts. I developed this system as a postdoctoral fellow, and used it to monitor how the eukaryotic replicative helicase copes with DNA damage. We plan to further extend the capabilities of this platform to directly visualize other essential replication factors, nucleosomes, and regulatory post-translational modifications like ubiquitin chains. By elucidating molecular mechanisms responsible for maintaining genome stability, we aim to better understand the link between genome instability and cancer, and how these mechanisms can be harnessed to improve disease treatment.
